Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Greif (GEF) Down 5.4% Since Last Earnings Report: Can It Rebound?

Published 01/06/2022, 11:30 PM
Updated 07/09/2023, 06:31 AM

It has been about a month since the last earnings report for Greif (NYSE:GEF). Shares have lost about 5.4% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Greif due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.

Greif Earnings & Sales Beat Estimates in Q4, Up Y/Y

Greif reported fourth-quarter fiscal 2021 adjusted EPS of $1.93, which surpassed the Zacks Consensus Estimate of $1.49. The bottom line increased 147% year on year.

Including one-time items, EPS was $1.74 in the quarter compared with 74 cents in the prior-year quarter.

Operational Update

Sales surged 36% year over year to $1,578 million. The top line beat the Zacks Consensus Estimate of $1,445 million.

Cost of sales was up 38% year over year to $1,282 million. Gross profit amounted to $296 million, up 28% from the prior-year quarter’s levels. Gross margin came in at 18.7% compared with the year-ago quarter’s 19.9%.

Selling, general and administrative (SG&A) expenses were up 22% year over year to $142 million. Adjusted operating profit soared 66% year over year to $154 million. Adjusted operating margin was 9.8% in the reported quarter compared with 8.0% in the year-earlier period. Adjusted EBITDA increased 37% year over year to $211 million in the fiscal fourth quarter.

Segmental Performance

Sales in the Global Industrial Packaging (NYSE:PKG) segment increased 46% year over year to $952 million. The segment’s adjusted EBITDA amounted to $121 million compared with the year-ago quarter’s $74 million.

The Paper Packaging segment sales rose 24% year over year to $622 million in the fiscal fourth quarter. The segment’s adjusted EBITDA moved up to $87.7 million from the prior-year quarter’s $77.4 million.

The Land Management segment’s sales totaled $4.9 million in the reported quarter compared with $6.7 million in the year-ago quarter. Adjusted EBITDA was $2.2 million, down from the year-earlier quarter’s $3 million.

Financials

As of fourth-quarter fiscal 2021-end, Greif reported cash and cash equivalents of $124.6 million, compared with $105.9 million as of the end of fiscal 2020. Cash flow from operating activities totaled $137 million in the quarter under review compared with $200 million in the prior-year quarter.

Long-term debt amounted to $2,054.8 million as of Oct 31, 2021, compared with $2,335.5 million as of Oct 31, 2020.

On Dec 7, Greif’s board announced a quarterly cash dividend of 46 cents per share of Class A Common Stock and 68 cents per share of Class B Common Stock. The dividend payout will be made on Jan 1 to shareholders of record at the close of business on Dec 17, 2021.

Fiscal 2021 Results

Greif reported an adjusted EPS of $5.60 for fiscal 2021 compared with $3.22 reported in fiscal 2020. Earnings also beat the Zacks Consensus Estimate of $5.16. Including one-time items, the bottom line came in at $6.54, up 257% from the $1.83 reported in fiscal 2020.

Sales increased 23% year over year to $5.56 billion. The top line also surpassed the Zacks Consensus Estimate of $5.42 billion.

Outlook

Given strong end-market demand, Greif expects fiscal 2022 adjusted EPS between $5.85 and $6.45. Adjusted free cash flow is anticipated between $400 million and $460 million.

How Have Estimates Been Moving Since Then?

Analysts were quiet during the last two month period as none of them issued any earnings estimate revisions.


Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

As one investor put it, “curing and preventing hundreds of diseases…what should that market be worth?” This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer (NYSE:SAM) Company which shot up +143.0% in little more than 9 months and NVIDIA (NASDAQ:NVDA) which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Greif, Inc. (GEF): Free Stock Analysis Report

To read this article on Zacks.com click here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.